Trends in primary care antidepressant prescribing 1995-2007: A longitudinal population database analysis

British Journal of General Practice

Volumn 61, Issue 590, 2011, Pages

  Lockhart, Pauline ^a   Guthrie, Bruce ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Antidepressant drugs; Family practice; Prescribing patterns; Scotland

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DOSULEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUPENTIXOL; FLUVOXAMINE; LOFEPRAMINE; MIRTAZAPINE; NEFAZODONE; PAROXETINE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; GENERAL PRACTITIONER; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRESCRIPTION; PRIMARY MEDICAL CARE; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; DRUG PRESCRIPTIONS; FEMALE; GENERAL PRACTICE; HUMANS; LENGTH OF STAY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PRESCRIPTION DRUGS; SCOTLAND; YOUNG ADULT;

EID: 83455236602     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp11X593848     Document Type: Article

References (24)

1. The World Bank. World development report: investing in health. Washington DC: World Bank and Oxford University Press, 1993.
2. Paykel E, Priest R. Recognition and management of depression in general practice: a consensus statement. BMJ 1992; 305(6863): 1198-1202.
3. Rix S, Paykel E, Lelliot P, et al. Impact of a national campaign on GP education: an evaluation of the Defeat Depression Campaign. Br J Gen Pract 1999; 49(439): 99-102. (Pubitemid 29068972)
4. NHS Quality Improvement Scotland. Clinical indicators report. Edinburgh: NHS Quality Improvement Scotland, 2007.
5. Hollinghurst S, Kessler D, Peters T, Gunnell D. Opportunity cost of antidepressant prescribing in England: analysis of routine data. BMJ 2005; 330(7498): 999-1000. (Pubitemid 40604282)
6. Mojtabai R. Increase in antidepressant medication in the US adult population between 1990 and 2003. Psychother Psychosom 2008; 77(2): 83-92. (Pubitemid 351172098)
7. World Health Organisation Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2011. Oslo: World Health Organization/Norwegian Institute of Public Health, 2011. http://www.whocc.no/atc-ddd-index/ (accessed 3 May 2011).
8. MacDonnell H. One in ten Scots taking antidepressants. The Scotsman 2008; 17 Dec: http://thescotsman.scotsman.com/scotland/One-in-ten-Scot-staking. 4799092.jp (accessed 12 Aug 2011).
9. Anonymous. Antidepressant prescribing soars. BBC News 2009. http://news.bbc.co.uk/go/pr/fr/-/1/hi/health/6653013.stm (Accessed 12 Aug 2011).
10. The Scottish Government. Scotland performs: HEAT antidepressant target. Edinburgh: Scottish Government, 2010. http://www.scotland.gov.uk/About/ scotPerforms/partnerstories/NHSScotlandperformance/Antidepressants (accessed 3 May 2011).
11. National Institute for Health and Clinical Excellence. Depression. The NICE guideline on the treatment and management of depression in adults. London: National Institute for Health and Clinical Excellence, 2009.
12. National Institute for Health and Clinical Excellence. Clinical guidelines for the management of anxiety in adults. London: National Institute for Health and Clinical Excellence, 2004.
13. Anderson I, Ferrier I, Baldwin R, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 2008; 22(4): 343-396. (Pubitemid 351989984)
14. Morrison J, Anderson M, Sutton M, et al. Factors influencing variation in prescribing of antidepressants by general practice in Scotland. Br J Gen Pract 2008; 59(559): e25-e31.
15. Moynihan R. Controversial disease dropped from Prozac product information. BMJ 2004; 328(7436): 365.
16. Munoz-Arroyo R, Sutton M, Morrison J. Exploring potential explanations for the increase in antidepressant prescribing in Scotland using secondary analysis of routine data. Br J Gen Pract 2005; 56(527): 423-428. (Pubitemid 43891224)
17. Moore M, Yuen HM, Dunn N, et al. Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. BMJ 2009; 339: b3999.
18. British Medical Asssociation and the Royal Pharmaceutical Society of Great Britain. British National Formulary 59. London: British Medical Asssociation and the Royal Pharmaceutical Society of Great Britain, 2010.
19. Scottish Index of Multiple Deprivation 2009 general report. Edinburgh: Office of the Chief Statistician, 2009.
20. General Register Office for Scotland. Summaries of Scotland's demographic facts. http://www.gro-scotland.gov.uk/statistics/index.html (accessed 3 May 2011).
21. Deshauer D, Moher D, Fergusson D, et al. Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials. Can Med Assoc J 2008; 178(10): 1293-1301. (Pubitemid 351678352)
22. National Collaborating Centre for Nursing and Supportive Care. Clinical practice guideline. Irritable bowel syndrome in adults: diagnosis and management of irritable bowel syndrome in primary care. London: National Institute for Health and Clinical Excellence, 2008.
23. Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol 2007; 63(2): 148-156. (Pubitemid 46072099)
24. Rudolph J, Salow M, Angelini M, McGlinchey R. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 2008; 168(5): 508-513. (Pubitemid 351547214)